Glioblastoma multiforme (GBM) is a rapidly progressive brain tumor with a median survival of 15-19 months. Therapeutic resistance and recurrence of the disease is attributed to cancer stem cells (CSC). Here, we report that CMV70-3P miRNA encoded by CMV increases GBM CSC stemness. Inhibition of CMV70-3P expression using oligo inhibitors significantly attenuated the ability of primary glioma cells to proliferate and form neurospheres. At the molecular level, we show that CM70-3P increases expression of cellular SOX2. Collectively, these findings indicate that CMV70-3P is a potential regulator of CMV- mediated glioma progression and cancer stemness.
CITATION STYLE
Ulasov, I. V., Kaverina, N. V., Ghosh, D., Baryshnikova, M. A., Kadagidze, Z. G., Karseladze, A. I., … Cobbs, C. S. (2017). CMV70-3P miRNA contributes to the CMV mediated glioma stemness and represents a target for glioma experimental therapy. Oncotarget, 8(16), 25989–25999. https://doi.org/10.18632/oncotarget.11175
Mendeley helps you to discover research relevant for your work.